Clareo Health | Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder
Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolar I Disorder or Schizoaffective Disorder
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assistance Publique Hopitaux De Marseille
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
over 18 years old;
diagnosed with schizophrenia, bipolar I disorder, or schizoaffective disorder
receiving ambulatory care by a treating psychiatrist, investigator
having been hospitalized under duress at least once during the year preceding the inclusion
being in decision-making jurisdiction
can be under curator
agreeing to participate in the study and with informed consent signed by the subject, as well as by the legal representative in the case of a person under guardianship.
You may not be if
less than 18 years old;
participating in another study simultaneously
in situations of decision-making incompetence
not able to read and write
refusing to participate in the study, or the legal representative refusing to participate in the study in the case of a person under guardianship.
